Published in Biol Psychiatry on April 01, 1989
Neurobiology of anorexia and bulimia nervosa. Physiol Behav (2007) 1.98
Localized brain volume and white matter integrity alterations in adolescent anorexia nervosa. J Am Acad Child Adolesc Psychiatry (2013) 1.03
White matter integrity is reduced in bulimia nervosa. Int J Eat Disord (2013) 0.85
Neuroimaging in eating disorders. Neuropsychiatr Dis Treat (2011) 0.81
Anorexia nervosa and sudden death in childhood: clinical data and results obtained from quantitative neurohistological investigations of cortical neurons. Eur Arch Psychiatry Clin Neurosci (1997) 0.78
Reduced Inferior and Orbital Frontal Thickness in Adolescent Bulimia Nervosa Persists Over Two-Year Follow-Up. J Am Acad Child Adolesc Psychiatry (2017) 0.75
Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med (1988) 3.98
Phase contrast cine magnetic resonance imaging. Magn Reson Q (1991) 3.06
MR fluoroscopy: technical feasibility. Magn Reson Med (1988) 2.52
Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev (2001) 1.90
Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging (1987) 1.90
Breast disease: dynamic spiral MR imaging. Radiology (1998) 1.89
CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol (1984) 1.55
Hypercortisolemia and hippocampal changes in depression. Psychiatry Res (1993) 1.52
Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry (1992) 1.41
Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. Am J Psychiatry (1988) 1.40
Quantitative magnetic resonance flow imaging. Magn Reson Q (1994) 1.38
The International Society for Magnetic Resonance in Medicine. Research directions in MR imaging. Radiology (1998) 1.38
MR spectroscopic imaging of collagen: tendons and knee menisci. Magn Reson Med (1995) 1.37
Evaluation of myocardial motion tracking with cine-phase contrast magnetic resonance imaging. Invest Radiol (1994) 1.19
Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci (1991) 1.19
Narcotic addiction among physicians: a ten-year follow-up. Am J Psychiatry (1966) 1.18
Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci (1993) 1.17
Pituitary size in depression. J Clin Endocrinol Metab (1991) 1.16
Single breath-hold pulmonary magnetic resonance angiography. Optimization and comparison of three imaging strategies. Invest Radiol (1994) 1.16
Tracking of cyclic motion with phase-contrast cine MR velocity data. J Magn Reson Imaging (1995) 1.15
Arterial and venous blood flow: noninvasive quantitation with MR imaging. Radiology (1992) 1.14
Mechanisms of contrast in NMR imaging. J Comput Assist Tomogr (1984) 1.13
Anterior cruciate ligament injury: fast spin-echo MR imaging with arthroscopic correlation in 217 examinations. AJR Am J Roentgenol (1998) 1.11
Amphetamine stereotypy: the influence of environmental factors and prepotent behavioral patterns on its topography and development. Biol Psychiatry (1975) 1.10
Rating the behavioral effects of amphetamine. Eur J Pharmacol (1974) 1.08
Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data. Radiographics (2001) 1.08
Intervertebral disk: normal age-related changes in MR signal intensity. Radiology (1990) 1.06
Meniscal tears of the knee: accuracy of detection with fast spin-echo MR imaging and arthroscopic correlation in 293 patients. Radiology (1997) 1.05
Assault and homicide associated with amphetamine abuse. Am J Psychiatry (1971) 1.05
Optimizing electrocardiograph electrode placement for cardiac-gated magnetic resonance imaging. Invest Radiol (1987) 1.05
Comparison of MR and contrast venography of the cervical venous system in multiple sclerosis. AJNR Am J Neuroradiol (2011) 1.04
Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. Radiology (1983) 1.04
Fast 3D cardiac cine MR imaging. J Magn Reson Imaging (1999) 1.02
Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry (1973) 1.01
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology (Berl) (1985) 1.01
Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam. J Pharmacokinet Biopharm (1990) 1.00
Cocaine dependence. Annu Rev Med (1989) 1.00
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res (1994) 1.00
Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry (1988) 0.99
Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology (1993) 0.96
Nuclear magnetic resonance imaging of atherosclerotic disease. Radiology (1983) 0.96
Freehand iMRI-guided large-gauge core needle biopsy: a new minimally invasive technique for diagnosis of enhancing breast lesions. J Magn Reson Imaging (2001) 0.95
Auditory habituation at primary cortex as a function of stimulus rate. Exp Neurol (1968) 0.94
Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients. Eur J Clin Pharmacol (1992) 0.94
Glenohumeral relationships during physiologic shoulder motion and stress testing: initial experience with open MR imaging and active imaging-plane registration. Radiology (1999) 0.93
Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology (1998) 0.93
1999 Gary J. Becker Young Investigator Award. MR-guided transjugular portosystemic shunt placement in a swine model. J Vasc Interv Radiol (1999) 0.93
Characterization of breast lesion morphology with delayed 3DSSMT: an adjunct to dynamic breast MRI. J Magn Reson Imaging (2000) 0.92
Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study. Acta Psychiatr Scand (1992) 0.92
Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biol Psychiatry (1980) 0.92
Magnetic resonance imaging evaluation of pulmonary vascular malformations. Chest (1994) 0.91
Silicone breast implant rupture: pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography, and ultrasound. Plast Reconstr Surg (1999) 0.91
Renal artery blood flow: quantitation with phase-contrast MR imaging with and without breath holding. Radiology (1994) 0.91
Stimulants: interaction with clinically relevant drugs. Ann N Y Acad Sci (1976) 0.91
Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse (2001) 0.90
Detection of patent coronary bypass grafts by computed tomography. A preliminary report. Circulation (1980) 0.90
Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. Pharmacol Biochem Behav (1992) 0.89
MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. AJNR Am J Neuroradiol (1992) 0.89
Nuclear magnetic resonance imaging of the infarcted muscle: a rat model. Radiology (1983) 0.89
Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. Psychopharmacology (Berl) (1995) 0.89
In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab (1990) 0.89
Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology (Berl) (1996) 0.88
Effects of turbulence on signal intensity in gradient echo images. Invest Radiol (1988) 0.88
In vivo stereological assessment of caudate volume in man: effect of normal aging. Life Sci (1990) 0.88
Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci (1991) 0.88
Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology (1987) 0.87
Cine MR determination of left ventricular ejection fraction. AJR Am J Roentgenol (1987) 0.87
Characterization of atherosclerosis with a 1.5-T imaging system. J Magn Reson Imaging (1993) 0.87
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging (1999) 0.86
In vivo stereological assessment of human cerebellar volume: effects of gender and age. AJNR Am J Neuroradiol (1991) 0.86
Magnetic resonance imaging for the evaluation of hydronephrosis, reflux and renal scarring in children. J Urol (2001) 0.86
Amphetamine psychosis. II. Theoretical implications. Int J Neuropsychiatry (1968) 0.86
Simultaneous temporal resolution of cardiac and respiratory motion in MR imaging. Radiology (1995) 0.86
Tissue relaxation time: in vivo field dependence. Radiology (1985) 0.85
Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry (1984) 0.85
Cocaine-mediated impairment of cardiac conduction in the dog: a potential mechanism for sudden death after cocaine. J Pharmacol Exp Ther (1990) 0.85
In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Res (1992) 0.85
Individual patterns of immediate skin reactivity to mold extracts. Ann Allergy (1990) 0.85
Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci (1981) 0.85
MR imaging of the knee: preliminary results with a 3DFT GRASS pulse sequence. AJR Am J Roentgenol (1988) 0.85
Augmentation of the behavioral and electrophysiologic response to cocaine by chronic administration in the rat. Exp Neurol (1977) 0.84
Reverse tolerance to stimulant-induced abnormal behavior. Life Sci (1977) 0.84
Methamphetamine self-administration in the cat. Psychopharmacologia (1976) 0.84
Dynamic breast MRI with spiral trajectories: 3D versus 2D. J Magn Reson Imaging (2000) 0.84
A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biol Psychiatry (1990) 0.84
Herniation pits of the femoral neck: appearance at MR imaging. Radiology (1989) 0.84
Magnetic resonance imaging and measurement of blood flow. West J Med (1994) 0.83
Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience (1997) 0.83
Pituitary abnormalities in eating disorders: further evidence from MRI studies. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.83
Breast cancer: gadolinium-enhanced MR imaging with a 0.5-T open imager and three-point Dixon technique. Radiology (1998) 0.83
Computed tomography for follow-up of chronic aortic dissections. Radiology (1981) 0.83
Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J Neurosci Methods (2000) 0.82
Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. Neuropsychopharmacology (1998) 0.82
Potentiation of the behavioral and convulsant effects of cocaine by chronic administration in the rat. Pharmacol Biochem Behav (1977) 0.82
The effects of chronic cocaine pretreatment on kindled seizures and behavioral stereotypies. Exp Neurol (1979) 0.82
Quantitative differential pulmonary perfusion: MR imaging versus radionuclide lung scanning. Radiology (1993) 0.82
Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology (Berl) (1983) 0.82
Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. Psychopharmacology (Berl) (1997) 0.81
Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold: effects of interaction with a selective dopamine D1 antagonist SCH 39166. J Cardiovasc Pharmacol (1998) 0.81